Innovation and competition in advanced therapy medicinal products

Advanced therapy medicinal products (ATMPs), including gene therapy, cell therapy and tissue engineering products, represent a paradigm shift in health care, but they are expensive. E. Seoane‐Vazquez, V. Shukla and R. Rodriguez‐Monguio discuss ATMPs prospects for the generics market.[Image: see text...

Descripción completa

Detalles Bibliográficos
Autores principales: Seoane‐Vazquez, Enrique, Shukla, Vaishali, Rodriguez‐Monguio, Rosa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404110/
https://www.ncbi.nlm.nih.gov/pubmed/30770338
http://dx.doi.org/10.15252/emmm.201809992
Descripción
Sumario:Advanced therapy medicinal products (ATMPs), including gene therapy, cell therapy and tissue engineering products, represent a paradigm shift in health care, but they are expensive. E. Seoane‐Vazquez, V. Shukla and R. Rodriguez‐Monguio discuss ATMPs prospects for the generics market.[Image: see text]

Ejemplares similares